logo

For the Inventor, By the Inventor

Northbrook, IL, United States of America

Harman S Lowrie

This inventor holds 13 USPTO granted patents. Top assignee: G.d. Searle & Company. Active years: 1977-1993.

USPTO Granted Patents = 13

% Patents Active = 100.0

Average Co-Inventor Count = 2.1

ph-index = 4

Forward Citations = 40(Granted Patents)


Location History:

  • Glenview, IL (US) (1977 - 1984)
  • Northbrook, IL (US) (1985 - 1993)

Company Filing History:

goldMedal13 out of 1,323 
 
G.d. Searle & Company
 patents

Years Active: 1977-1993

Loading Chart...
13 patents (USPTO):Explore Patents
1. 5233063 - Metabolites of pentanedioic acid derivatives (1993-08-03),
2. 5055613 - Metabolites of pentanedioic acid derivatives (1991-10-08),
3. 5041694 - Substituted glutaric acid lactones in the treatment of hyperlipidemia (1991-08-20),
4. 5032584 - S-diastereomer of an n.sup.6 -((2-hydroxypropyl)aryl)adenosine and its (1991-07-16),
5. 5030624 - R-diastereomer of an N.sup.6 -[(2-hydroxypropyl)aryl]adenosine and its (1991-07-09),
6. 4965373 - Substituted glutaric acid lactones in the treatment of hyperlipidemia (1990-10-23),
7. 4895973 - Substituted glutaric acid lactones in the treatment of hyperlipidemia (1990-01-23),
8. 4707499 - 3-alkyl-5-(substituted amino)methyl)dihydro-3-phenyl-2(3H)-furanones and (1987-11-17),
9. 4645858 - Pentanedioic acid derivatives (1987-02-24),
10. 4622338 - Substituted glutaric acid lactones in the treatment of hyperlipidemia (1986-11-11),
11. 4554359 - 3-Substituted pentanedioic acids and derivatives thereof (1985-11-19),
12. 4473501 - Dihydro azino isoquinolines (1984-09-25),
13. 4035372 - 4-{[4-(Diphenylmethyl)-1-piperidinyl]methyl}benzenamines (1977-07-12),

Title: Harman S Lowrie: A Visionary Innovator in Pharmaceuticals

Introduction: Harman S Lowrie, a distinguished inventor based in Northbrook, IL (US), has left an indelible mark on the world of inventions with his relentless pursuit of innovation and his passion for creating a positive impact. His remarkable legacy is characterized by a deep commitment to pushing the boundaries of science and technology.

Latest Patents: With an impressive portfolio of 13 patents, Harman S Lowrie continues to revolutionize the field of pharmaceuticals. His latest patents, including "Metabolites of pentanedioic acid derivatives," underscore his pioneering work in developing hypolipidemic drugs. These compounds have the potential to transform the treatment of various medical conditions.

Career Highlights: Harman S Lowrie's career at G.D. Searle & Company has been nothing short of extraordinary. His innovative spirit and unwavering dedication to research have led to groundbreaking discoveries in the pharmaceutical industry. Through his patented inventions, he has paved the way for new advancements in healthcare and medicine.

Collaborations: Collaborating with esteemed coworkers such as John S Baran and Thomas J Lindberg, Harman S Lowrie has fostered a culture of creativity and collaboration. Together, they have harnessed their collective expertise to tackle complex challenges and drive innovation forward. Their synergistic efforts have undoubtedly contributed to the success of their projects.

Conclusion: Harman S Lowrie's legacy as a visionary innovator in pharmaceuticals serves as an inspiration to aspiring inventors worldwide. His contributions have not only enriched the field of inventions but have also touched the lives of countless individuals through his groundbreaking work in developing life-saving medications. As he continues to push the boundaries of innovation, Harman S Lowrie stands as a testament to the transformative power of ingenuity and perseverance in shaping a better future for all.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…